# Ravi Salgia
**Type:** Researchers
**Canonical URL:** https://scholariq.org/researchers/ravi-salgia/
## Facts
| Field | Value |
| --- | --- |
| Citations | 49,631 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 110 |
| i10-index | 495 |
| Last Known Institution | City Of Hope National Medical Center |
| OpenAlex ID | https://openalex.org/A5003826371 |
| ORCID iD | 0000-0001-9643-7626 |
| Works | 1,167 |
## Researcher papers
Showing 12 of 13.
- [Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer](https://scholariq.org/papers/anaplastic-lymphoma-kinase-inhibition-in-non-small-cell-lung-cancer/)
- [Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer](https://scholariq.org/papers/crizotinib-in-i-ros1-i-rearranged-non-small-cell-lung-cancer/)
- [Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations](https://scholariq.org/papers/development-of-pd-1-and-pd-l1-inhibitors-as-a-form-of-cancer-immunotherapy-a/)
- [Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study](https://scholariq.org/papers/activity-and-safety-of-crizotinib-in-patients-with-alk-positive-non-small-cell/)
- [Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis](https://scholariq.org/papers/effect-of-crizotinib-on-overall-survival-in-patients-with-advanced-non-small/)
- [Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors](https://scholariq.org/papers/activation-of-met-via-diverse-exon-14-splicing-alterations-occurs-in-multiple/)
- [Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion](https://scholariq.org/papers/targeting-fto-suppresses-cancer-stem-cell-maintenance-and-immune-evasion/)
- [The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups](https://scholariq.org/papers/the-american-association-for-thoracic-surgery-guidelines-for-lung-cancer/)
- [Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer](https://scholariq.org/papers/inhibition-of-mitochondrial-fission-prevents-cell-cycle-progression-in-lung/)
- [Functional Expression and Mutations of c-Met and Its Therapeutic Inhibition with SU11274 and Small Interfering RNA in Non–Small Cell Lung Cancer](https://scholariq.org/papers/functional-expression-and-mutations-of-c-met-and-its-therapeutic-inhibition-with/)
- [MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib](https://scholariq.org/papers/i-met-i-amplification-identifies-a-small-and-aggressive-subgroup-of/)
- [Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial](https://scholariq.org/papers/activity-and-safety-of-brigatinib-in-alk-rearranged-non-small-cell-lung-cancer/)
## Researcher topics
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Liver physiology and pathology](https://scholariq.org/topics/liver-physiology-and-pathology/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
## Researcher university
- [City Of Hope National Medical Center](https://scholariq.org/institutions/city-of-hope-national-medical-center/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.